Cancer Research UK, the world's largest independent cancer research body, has appointed a new chief executive.
Alex Markham, currently director of the Molecular Medicines Unit at the University of Leeds and honorary consultant physician at Leeds Teaching Hospital NHS Trust, will take up his new position in September 2003.
The job of chief executive became available after Paul Nurse announced earlier this year he was leaving to become president of Rockefeller University in New York.
In addition to his clinical and academic posts, Markham serves on the Department of Health's Committee on Safety of Medicines and is also involved with the government's Gene Therapy Advisory Committee.
Announcing the appointment Tuesday (June 17), Cancer Research UK said in a press statement that Markham, who is 52, "has also held senior advisory roles for the Medical Research Council and the Wellcome Trust and has extensive management experience in the pharmaceutical industry."
Markham ...
